In a multi-stakeholder industry such as that of Orphan Drugs, communication is vital to ensuring strong, effective working relationships. Charles Stark from Emmaus Lifesciences joined us at the World Orphan Drug Congress USA 2016 to key his tips on managing relationships with KOLs. Although a specific example, the tips he provides would work in a variety of scenarios.
Maintaining a relationship based on trust: finding common goals with a KOL and its institution, and maneuvering communications between people internally and externally
- Relationship initiation, development and maintenance including identifying key stakeholders outside KOLs
- Finding mutual areas of expertise, needs, and deliverables for goals
- Types of business relationships: patents, rights to publications, partnership, grants payments for services, etc.
Join us at the World Orphan Drug Congress USA 2017 for more insight into the multi-stakeholder landscape of Orphan Drugs.